Citigroup Inc Elanco Animal Health Inc Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Citigroup Inc holds 236,042 shares of ELAN stock, worth $2.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
236,042
Previous 570,123
58.6%
Holding current value
$2.84 Million
Previous $8.23 Million
57.88%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ELAN
# of Institutions
435Shares Held
472MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$1 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$633 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$589 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$281 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$256 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.71B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...